These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 16285959
21. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest. Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N. Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499 [Abstract] [Full Text] [Related]
22. [Research on promoter region methylation status of tumor repressor gene P16 in human hepatocellular carcinoma by using methylation sensitive restriction enzyme and semi-nested PCR assay]. Jiang L, Qin Y, Sun ZL, Sun ZF, Wang JH, Yang LC. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 15; 38(1):53-6. PubMed ID: 17294727 [Abstract] [Full Text] [Related]
23. Characterization of the human SLC22A18 gene promoter and its regulation by the transcription factor Sp1. Ali AM, Bajaj V, Gopinath KS, Kumar A. Gene; 2009 Jan 15; 429(1-2):37-43. PubMed ID: 18996451 [Abstract] [Full Text] [Related]
24. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma. Sakai M, Hibi K, Kanazumi N, Nomoto S, Inoue S, Takeda S, Nakao A. Hepatogastroenterology; 2005 Jan 15; 52(66):1854-7. PubMed ID: 16334792 [Abstract] [Full Text] [Related]
25. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin. Li JL, Fei Q, Yu J, Zhang HY, Wang P, Zhu JD. Ai Zheng; 2004 Sep 15; 23(9):985-91. PubMed ID: 15363188 [Abstract] [Full Text] [Related]
26. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Mancini DN, Singh SM, Archer TK, Rodenhiser DI. Oncogene; 1999 Jul 15; 18(28):4108-19. PubMed ID: 10435592 [Abstract] [Full Text] [Related]
27. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H, Goldberg E. J Androl; 2009 Jul 15; 30(2):157-67. PubMed ID: 18930904 [Abstract] [Full Text] [Related]
28. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Yau TO, Chan CY, Chan KL, Lee MF, Wong CM, Fan ST, Ng IO. Oncogene; 2005 Feb 24; 24(9):1607-14. PubMed ID: 15580286 [Abstract] [Full Text] [Related]
29. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP, Harya NS, Hutzley J, Bacich DJ, Monzon FA, Chandran U, Dhir R, O'Keefe DS. Prostaglandins Other Lipid Mediat; 2007 Jan 24; 82(1-4):185-97. PubMed ID: 17164146 [Abstract] [Full Text] [Related]
30. Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. Liedtke C, Gröger N, Manns MP, Trautwein C. J Hepatol; 2006 Feb 24; 44(2):342-9. PubMed ID: 16225956 [Abstract] [Full Text] [Related]
31. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity. Guarcello V, Blanquicett C, Naguib FN, El Kouni MH. Cancer Chemother Pharmacol; 2008 Jun 24; 62(1):85-96. PubMed ID: 17805539 [Abstract] [Full Text] [Related]
32. The role of CpG methylation in cell type-specific expression of the aquaporin-5 gene. Nomura J, Hisatsune A, Miyata T, Isohama Y. Biochem Biophys Res Commun; 2007 Feb 23; 353(4):1017-22. PubMed ID: 17198683 [Abstract] [Full Text] [Related]
33. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells. Hubé F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y. Biol Chem; 2003 Jul 23; 384(7):1029-34. PubMed ID: 12956419 [Abstract] [Full Text] [Related]
34. An epigenetic mechanism regulates germ cell-specific expression of the porcine Deleted in Azoospermia-Like (DAZL) gene. Linher K, Cheung Q, Baker P, Bedecarrats G, Shiota K, Li J. Differentiation; 2009 Apr 23; 77(4):335-49. PubMed ID: 19281782 [Abstract] [Full Text] [Related]
35. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. Macheiner D, Heller G, Kappel S, Bichler C, Stättner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zöchbauer-Müller S, Grasl-Kraupp B. J Hepatol; 2006 Jul 23; 45(1):81-9. PubMed ID: 16516329 [Abstract] [Full Text] [Related]
36. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L. Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889 [Abstract] [Full Text] [Related]
37. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. Cho S, Lee JH, Cho SB, Yoon KW, Park SY, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS. Pathol Int; 2010 Mar 01; 60(3):203-11. PubMed ID: 20403046 [Abstract] [Full Text] [Related]
38. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma. Gonzalez-Gomez P, Bello MJ, Inda MM, Alonso ME, Arjona D, Amiñoso C, Lopez-Marin I, de Campos JM, Sarasa JL, Castresana JS, Rey JA. Oncol Rep; 2004 Sep 01; 12(3):663-6. PubMed ID: 15289853 [Abstract] [Full Text] [Related]
39. Structure of the human 5-HT7 receptor gene and characterization of its promoter region. Laenen K, Haegeman G, Vanhoenacker P. Gene; 2007 Apr 15; 391(1-2):252-63. PubMed ID: 17321075 [Abstract] [Full Text] [Related]
40. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Matsumura T, Makino R, Mitamura K. Clin Cancer Res; 2001 Mar 15; 7(3):594-9. PubMed ID: 11297254 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]